This column highlights the most interesting and useful biotech news from around the Web every Thursday.   Pharmalot Link: HIV Prevention-In-A-Pill Is A Must: Mitch Explains "An FDA advisory panel meets today to review a controversial move by Gilead Sciences (GILD) to seek approval to market its Truvada HIV pill to prevent infection which is also known as pre-exposure prophylaxis or PrEP. The move was both welcomed and criticized by AIDS activists reflecting a spectrum of views on making a preventive pill available on a large-scale basis. To some FDA approval would offer needed assistance in containing HIV and possibly clarify the extent ...